摘要
1 mTOR的结构与功能mTOR是一种大分子蛋白质,分子量为289kDa,由2459个氨基酸分子组成,如图1所示,mTOR蛋白激酶域位于分子的C端。
出处
《河北医学》
CAS
2011年第5期694-697,共4页
Hebei Medicine
参考文献18
-
1Nissim H,Nahum S.Upstream and downstream of mTOR[J].Genes Dev.2004,18(16):1926-1945. 被引量:1
-
2Choi J,Chen J,Schreiber SL,et al.Structure of the FKBP12?rapamycin complex interacting with the binding domain of human FRAP[J].Science.1996,273:239-342. 被引量:1
-
3Jacinto E,Loewith R,Schmidt A,et al.Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive[J].Nat Cell Biol,2004,6:1122-1128. 被引量:1
-
4Andrew C,Hsieh,Maria Costa,et al.Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E[J].Cancer Cell,2010,17(3):249-261. 被引量:1
-
5Dufner A,Thomas J.Ribosomal S6 kinase signaling and the control of translation[J].Exp Cell Res,1999,253:100-109. 被引量:1
-
6Vezina C,Kudelski A,Sehgal SN.Rapamycin (AY?22,989),a new antifungal antibiotic.I.Taxonomy of the producing streptomycete and isolation of the active principle[J].Antibiot (Tokyo),1975,28:721-726. 被引量:1
-
7Cejka D,Preusser M,Fuereder T,et al.mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo[J].Anticancer Res,2008,28(6A):3801-3808. 被引量:1
-
8Hosono Y,Osada S,Nawa M,et al.Combination therapy of 5-fluorouracil with rapamycin for hormone receptor-negative human breast cancer[J].Anticancer Res,2010,30(7):2625-2630. 被引量:1
-
9Perl AE,Kasner MT,Tsai DE,et al.A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia[J].Clin Cancer Res,2009,15(21):6732-6739. 被引量:1
-
10Rizell M,Andersson M,Cahlin C,et al.Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer[J].Int Clin Oncol,2008,13(1):66-70. 被引量:1
同被引文献34
-
1Noh WC, Kim YH, Kim MS, et al. Activation of the mTOR signaling pathway in breast cancer and its correlation with the ctinicopatholngic variables[J]. Breast Cancer Res Treat ,2008,110(3):477-483. 被引量:1
-
2Martelli AM, Evangelisti C, Chiarini F, et al. The phosphatidyli- nositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients[J]. Oncotarget, 2010,1 (2) : 89-103. 被引量:1
-
3Maehama T,Dixon JE. The tumor suppressor,PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinosi- tol 3,4,5-trisphosphate[J]. J Biol Chem, 1998,273(22) : 13375- 13378. 被引量:1
-
4Steelman LS,Navolanic PM,Sokolosky ML,et al. Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to roTOR inhibitors[J]. Oneogene,2008,27(29) :4086-4095. 被引量:1
-
5Bae-Jump VL,Zhou C,Boggess JF,et al. Rapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatment[J]. Gynecol On- col,2010,119(3) :579-585. 被引量:1
-
6Fang Y,Vilella-Bach M,Bachmann R,et al.Phosphatidic acid mediated mitogenie aactivation of mTOR signaling[J].Science,2001,294(5548):1942-1945. 被引量:1
-
7贾海泉,蔺会云,徐元基,等.MAG-1对肿瘤细胞迁移、黏附和侵袭能力的影响及其作用机制的研究[C].第五届中国肿瘤学术大会暨第七届海峡两岸肿瘤学术会议、国际肿瘤细胞与基因治疗学术会议、第二届中日肿瘤介入治疗学术会议论文集,2008:190-205. 被引量:1
-
8Wang Y,Jia H,Lin H,et al.Metastasis-associated gene,MAG-1 improves tumor microenvironmental adaptation and potentiates tumor metastasis[J].J Cell Mol Med,2012,16(12):3037-3051. 被引量:1
-
9Joseph Avruch,Xiaomeng Long,Yenshou Lin,et al.Activation of mTORC1 in two steps:Rheb-GTP activation of catalytic function and increased binding of substrates to raptor[J].Biochem Society Transactions,2009,37(1):223-226. 被引量:1
-
10Ryan C Russell,Chong Fang,Kun-Liang Guan.An emerging role for TOR signaling in mammalian tissue and stem cell physiology[J].Development,2011,138(16):3343-3356. 被引量:1
引证文献2
-
1李田,杨越波,孟丽荣,李小毛,许成芳,李征然.雷帕霉素抑制子宫内膜癌裸鼠移植瘤生长活体成像的观察[J].中华肿瘤防治杂志,2011,18(16):1221-1224. 被引量:4
-
2杨云琳,杨娟,任明智,赵长林.MAG-1和mTOR生物学功能研究进展[J].现代肿瘤医学,2014,22(3):723-725. 被引量:4
二级引证文献8
-
1郭婧昀,姚广裕,顾繁,陈路嘉,陈睿婷,李文姬,叶长生.曲妥珠单抗对HER-2过表达乳腺癌细胞株mTOR信号通路影响的观察[J].中华肿瘤防治杂志,2012,19(13):983-986. 被引量:5
-
2吴洁玲,韩璐,杨丽肖.雷帕霉素联合顺铂对宫颈癌Hela细胞生长和对HIF-1α与VEGF表达影响的观察[J].中华肿瘤防治杂志,2013,20(14):1075-1078. 被引量:7
-
3高超,孔姝婧,赵晶,朱艳卿,裴东升.雷帕霉素联合紫杉醇对SGC-7901增殖影响的研究[J].中华肿瘤防治杂志,2014,21(2):105-108. 被引量:4
-
4周俊梅,韦芳,刘素君,张必萌.艾灸抑制小鼠皮下移植瘤生长的活体成像观察[J].现代肿瘤医学,2014,22(10):2263-2266.
-
5王广胜,朱晨宇,杨振华,刘超,朱耀明,商远方.雷帕霉素单独及联合化疗药物应用对胃癌细胞生长的影响[J].现代肿瘤医学,2016,24(13):2019-2022. 被引量:3
-
6唐源,王阳,陈世豪,李华,温省初,王一飞,刘学潮.雷帕霉素对人淋巴瘤Raji细胞增殖、VEGF-A及HIF-1α表达的影响[J].现代肿瘤医学,2017,25(8):1179-1183. 被引量:1
-
7刘斌,杨云琳,周永娜,赵长林,任明智,宫爱民.直肠癌组织中转移相关基因-1和哺乳动物雷帕霉素靶蛋白的表达与临床病理特征的相关性[J].中国医师进修杂志,2017,40(5):394-398. 被引量:2
-
8李正龙,李鑫恒,郑汪洋,李景林,王志东,崔云甫,姜兴明.环状RNA在消化系统肿瘤中的研究进展[J].现代肿瘤医学,2017,25(17):2855-2858. 被引量:1
-
1高玉雷,吕艺,柴艳芬,李俊聪,董宁,祝筱梅,张庆红,姚咏明.Exendin-4对小鼠巨噬细胞一氧化氮生成和促炎/抗炎反应平衡的影响[J].感染.炎症.修复,2013,14(4):201-206. 被引量:1
-
2吴洁玲,韩璐,杨丽肖.雷帕霉素联合顺铂对宫颈癌Hela细胞生长和对HIF-1α与VEGF表达影响的观察[J].中华肿瘤防治杂志,2013,20(14):1075-1078. 被引量:7
-
3史妍婷,井欢,王莹,易佳丽,刘春英.补中益气汤含药血清逆转A549/DDP的顺铂耐药及对mTOR表达的影响[J].中国实验方剂学杂志,2013,19(9):215-219. 被引量:18
-
4维宣.神奇的分子——药物如何在我们身体里起作用[J].现代健康人,2004,7(8):40-41.
-
5丁英钧,陈亮,王海蓉,王宏涛.通心络超微粉联合津力达颗粒对糖尿病肾病大鼠Akt/mTOR信号转导通路的影响[J].中国实验方剂学杂志,2016,22(5):110-114. 被引量:8
-
6徐巧玲,蔡小兵.银杏叶提取物药理研究进展[J].人民军医,2004,47(10):609-611. 被引量:12
-
7伊利亚尔·买买提力,俞瑾,郭海,郑宏.mTOR 在缺氧预处理减轻乳鼠离体心肌细胞氧糖缺失/复氧复糖损伤中的作用[J].中华麻醉学杂志,2014,34(3):363-365. 被引量:1
-
8董靖,向光大,向林,王浩华,刘敏.软脂酸对人脐静脉内皮细胞凋亡影响及其机制的研究[J].中国糖尿病杂志,2013,21(5):459-463. 被引量:1
-
9董靖,向光大,向林,王浩华,刘敏.高糖诱导人脐静脉内皮细胞凋亡的机制[J].临床内科杂志,2013,30(4):275-278. 被引量:1
-
10李妍,赵良中,李强,曹慧玲.紫杉醇与mTOR抑制剂雷帕霉素联合抑制非小细胞肺癌增殖[J].同济大学学报(医学版),2010,31(4):39-42. 被引量:1